Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Immunotherapy|May 4, 2013
General overview of radioimmunotherapy of solid tumorsIsabelle Navarro-Teulon, Catherine Lozza, André Pèlegrin, et al.Frontiers in Oncology|October 5, 2013
Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancersCatherine Lozza, Isabelle Navarro-Teulon, André Pèlegrin, et al.Frontiers in Medicine|April 9, 2015
Introduction to radiobiology of targeted radionuclide therapyJean-Pierre Pouget, Catherine Lozza, Emmanuel Deshayes, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 27, 2007
Functional imaging of working memory in Parkinson's disease: compensations and deficitsRose-Marie Marié, Catherine Lozza, Chantal Chavoix, et al.Future Science OA|January 13, 2021
Low-dose colchicine prevents sympathetic denervation after myocardial ischemia-reperfusion: a new potential protective mechanismFabien Huet, Jérémy Fauconnier, Marion Legall, et al.Human Brain Mapping|June 15, 2004
Executive processes in Parkinson's disease: FDG-PET and network analysisCatherine Lozza, Jean-Claude Baron, David Eidelberg, et al.Cells|February 25, 2023
Transfer of Cardiac Mitochondria Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in a Preclinical Model of Ischemic Heart DiseaseMarie-Luce Vignais, Jennyfer Levoux, Pierre Sicard, et al.Antioxidants & Redox Signaling|May 26, 2016
Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted EffectsSalomé Paillas, Riad Ladjohounlou, Catherine Lozza, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 21, 2018
Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian CancerEmmanuel Deshayes, Riad Ladjohounlou, Pierre Le Fur, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger RadioimmunotherapyRiad Ladjohounlou, Catherine Lozza, Alexandre Pichard, et al.Pageof 1